Traditional approval of encorafenib plus cetuximab and fluorouracil-based chemotherapy for patients with BRAF-mutated metastatic colorectal cancer follows accelerated approval 2 years ago.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-grants-full-approval-encorafenib-metastatic-crc-2026a10005zm?src=rss
Author :
Publish date : 2026-02-25 17:54:00
Copyright for syndicated content belongs to the linked Source.
